Sabine Schirm

1.7k total citations · 1 hit paper
27 papers, 1.5k citations indexed

About

Sabine Schirm is a scholar working on Oncology, Hepatology and Epidemiology. According to data from OpenAlex, Sabine Schirm has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Sabine Schirm's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Herpesvirus Infections and Treatments (5 papers). Sabine Schirm is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Herpesvirus Infections and Treatments (5 papers). Sabine Schirm collaborates with scholars based in United States, Switzerland and Germany. Sabine Schirm's co-authors include J. Michael Bishop, Martin Eilers, W. Schaffner, Josef Jiricny, Walter Doerfler, Bernhard Fleckenstein, Anthony Johns, David R. Light, Ronald C. Desrosiers and Ingrid Müller and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Sabine Schirm

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The MYC protein activates transcription of the alpha-prothymosin gene.

1991 526 citations Martin Eilers, Sabine Schirm et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Sabine Schirm

Since Specialization

Citations

This map shows the geographic impact of Sabine Schirm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Schirm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Schirm more than expected).

Fields of papers citing papers by Sabine Schirm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Schirm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Schirm. The network helps show where Sabine Schirm may publish in the future.

Co-authorship network of co-authors of Sabine Schirm

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Schirm. A scholar is included among the top collaborators of Sabine Schirm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Schirm. Sabine Schirm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer 2017 ·Journal of Gastrointestinal Oncology ·Andrew S. Kennedy, David S. Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, (unknown), (unknown), Fred M Moeslein, Charles Nutting, Samuel Putnam, Steven C. Rose, Michael A. Savin, Sabine Schirm, Navesh Sharma, Eric W. Wang	15
2	Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer 2015 ·Clinical Colorectal Cancer ·Andrew S. Kennedy, David S. Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, (unknown), Steven C. Rose, Charles Nutting, Fred M Moeslein, Michael A. Savin, Sabine Schirm, Samuel Putnam, Navesh Sharma, Eric A. Wang	12
3	Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres. 2015 ·PubMed ·Andrew S. Kennedy, David S. Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, (unknown), Steven C. Rose, Charles Nutting, Fred M Moeslein, Michael A. Savin, Sabine Schirm, Samuel Putnam, Navesh Sharma, Eric A. Wang	65
4	Hepatic imaging response to ⁹⁰y-microsphere therapy administered for tumor progression during systemic chemotherapy in patients with colorectal liver metastases. 2013 ·Journal of Clinical Oncology ·Andrew S. Kennedy, David S. Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, (unknown), (unknown), Charles Nutting, Fred M Moeslein, Samuel Putnam, Steven C. Rose, Michael A. Savin, Sabine Schirm, Navesh Sharma, Eric W. Wang	3
5	U.S. patients receiving resin ⁹⁰Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients. 2012 ·Journal of Clinical Oncology ·Andrew S. Kennedy, David S. Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, (unknown), (unknown), Steven C. Rose, Charles Nutting, Fred M Moeslein, Michael A. Savin, Sabine Schirm, Navesh Sharma, Eric W. Wang	6
6	Fragmented Tissue Factor Pathway Inhibitor (TFPI) and TFPI C‐Terminal Peptides Eliminate Serum‐ResistantEscherichia colifrom Blood Cultures 2009 ·The Journal of Infectious Diseases ·Sabine Schirm, Xu Liu, Lori L. Jennings, Paul T. Jedrzejewski, (unknown), Stephen Hardy	16
7	Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): In vitro effects on platelets 2008 ·Thrombosis Research ·Judi Bryant, Joseph Post, (unknown), Yixin Wang, (unknown), Sabine Schirm, Jih‐Lie Tseng, Babu Subramanyam, Brad O. Buckman, Imadul Islam, Shendong Yuan, Mark Sullivan, (unknown), John Morser	26
8	Cloning and characterization of the rat HIF-1α prolyl-4-hydroxylase-1 gene 2005 ·Protein Expression and Purification ·Ronald R. Cobb, John McClary, (unknown), (unknown), Brent Larsen, Eric Blasko, Jennifer Pearson, Sara Biancalana, Katalin Kauser, Peter Bringmann, David R. Light, Sabine Schirm	1
9	Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis 2005 ·Circulation ·Yixin Wang, Baby Martin-McNulty, Valdeci da Cunha, Jon Vincelette, Xiangru Lu, Qingping Feng, Meredith Halks‐Miller, Mithra Mahmoudi, (unknown), Babu Subramanyam, Jih‐Lie Tseng, (unknown), Sabine Schirm, Anthony Johns, Katalin Kauser, William P. Dole, David R. Light	105
10	FXa-Induced Responses in Vascular Wall Cells are PAR-Mediated and Inhibited by ZK-807834 2001 ·Thrombosis Research ·Kirk Mclean, Sabine Schirm, Anthony Johns, John Morser, David R. Light	45
11	Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2 1997 ·Oncogene ·Annette Hogg, Sabine Schirm, Hideki Nakagoshi, Paul B. Bartley, Shunsuke Ishii, J. Michael Bishop, Thomas J. Gonda	53
12	The MYC protein activates transcription of the alpha-prothymosin gene. breakdown → 1991 ·The EMBO Journal ·Martin Eilers, Sabine Schirm, J. Michael Bishop	526
13	MYB and MYC in the Cell Cycle 1991 ·Cold Spring Harbor Symposia on Quantitative Biology ·J. Michael Bishop, Martin Eilers, Alisa L. Katzen, Thomas B. Kornberg, Gary Ramsay, Sabine Schirm	26
14	Pseudorabies virus immediate-early gene overlaps with an oppositely oriented open reading frame: Characterization of their promoter and enhancer regions 1990 ·Virology ·Čestmı́r Vlček, Zbyněk Kozmík, Václav Pačes, Sabine Schirm, (unknown)	51
15	A temperature-sensitive phenotype of avian myeloblastosis virus: determinants that influence the production of viral mRNAs 1990 ·Journal of Virology ·Sabine Schirm, (unknown), J. Michael Bishop	11
16	Redundancy of information in enhancers as a principle of mammalian transcription control 1988 ·Journal of Molecular Biology ·G. Schaffner, Sabine Schirm, (unknown), Frank Weber, Walter Schaffner	56
17	The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. 1987 ·Genes & Development ·Sabine Schirm, Josef Jiricny, W. Schaffner	247
18	Herpesvirus saimiri DNA in a lymphoid cell line established by in vitro transformation 1984 ·Journal of Virology ·Sabine Schirm, Ingrid Müller, Ronald C. Desrosiers, Bernhard Fleckenstein	48
19	Cloning of Herpesvirus saimiri DNA fragments representing the entire L-region of the genome 1983 ·Gene ·Elisabeth Knust, Sabine Schirm, (unknown), Walter Bodemer, (unknown), Bernhard Fleckenstein	37
20	Expression of Viral DNA in Adenovirus Type 12-Transformed Cells, in Tumor Cells, and in Revertants 1981 ·Journal of Virology ·Sabine Schirm, Walter Doerfler	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact